Skip to main content
Log in

Immunohistochemical detection of the Raf kinase inhibitor protein in nonneoplastic gastric tissue and gastric cancer tissue

  • Original Paper
  • Published:
Medical Oncology Aims and scope Submit manuscript

Abstract

Expression of the Raf kinase inhibitor protein (RKIP), a metastasis suppressor, is high in normal tissues, low in primary cancers, and lowest or absent in metastatic cancers. Here, we studied the expression of RKIP in nonneoplastic gastric tissue and gastric cancer tissue by immunohistochemistry (IHC) and evaluated its role in the genesis and metastasis of gastric cancer. RKIP immunoreactivity was evaluated in 40 samples of nonneoplastic gastric tissues and 75 samples of gastric cancer tissues. Among the 40 samples of nonneoplastic gastric tissue, 35 (87.5%) were positive for RKIP expression and 5 (12.5%) were negative; in the 75 samples of primary gastric cancer tissue, 39 (52%) were positive for RKIP expression and 36 (48%) were negative. Among 26 samples of metastatic lymph node tissues, 5 (19.2%) were positive for RKIP expression and 21 (80.8%) were negative. RKIP expression level was highest in nonneoplastic gastric tissue, low in primary gastric cancer tissue, and lowest or undetectable in metastatic gastric cancer tissue. Our data suggest that RKIP may play a role in the genesis and metastasis of gastric cancer.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

  1. Bernier I, Jolles P. Purification and characterization of a basic 23 kD acytosolic protein from bovine brain. Biochim Biophys Acta. 1984;790:174–81.

    CAS  PubMed  Google Scholar 

  2. Fu Z, et al. Effects of raf kinase inhibitor protein expression on suppression of prostate cancer metastasis. J Natl Cancer Inst. 2003;95(12):878–89.

    Article  CAS  PubMed  Google Scholar 

  3. Simister PC, Banfield MJ, Brady RL. The crystal structure of PEBP-2, a homologue of the PEBP/RKIP family. Acta Crystallogr D Biol Crystallogr. 2002;58(Pt 6/Pt 2):1077–80.

    Article  CAS  PubMed  Google Scholar 

  4. Trakul N, Rosner MR. Modulation of the MAP kinase signaling cascade by Raf kinase inhibitory protein. Cell Res. 2005;15:19–23. doi:10.1038/sj.cr.7290258.

    Article  CAS  PubMed  Google Scholar 

  5. Trakul N, et al. Raf kinase inhibitory protein regulates Raf-1 but not B-Raf kinase activation. J Biol Chem. 2005;280:24931–40. doi:10.1074/jbc.M413929200.

    Article  CAS  PubMed  Google Scholar 

  6. Yeung K, et al. Suppression of Raf-1 kinase activity and MAP kinase signalling by RKIP. Nature. 2002;401:173–7.

    Google Scholar 

  7. Yeung KC, et al. Raf kinase inhibitor protein interacts with NF-kappaBinducing kinase and TAK1 and inhibits NF-kappaB activation. Mol Cell Biol. 2001;21:7207–17. doi:10.1128/MCB.21.21.7207-7217.2001.

    Article  CAS  PubMed  Google Scholar 

  8. Chatterjee D, et al. RKIP sensitizes prostate and breast cancer cells to drug-induced apoptosis. J Biol Chem. 2004;279:17515–23. doi:10.1074/jbc.M313816200.

    Article  CAS  PubMed  Google Scholar 

  9. Lee HC, et al. Loss of Raf kinase inhibitor protein promotes cell proliferation and migration of human hepatoma cells. Gastroenterology. 2006;131:1208–17. doi:10.1053/j.gastro.2006.07.012.

    Article  CAS  PubMed  Google Scholar 

  10. Al-Mulla F, et al. Raf kinase inhibitor protein expression in a survival analysis of colorectal cancer patients. J Clin Oncol. 2006;24:5672–9. doi:10.1200/JCO.2006.07.5499.

    Article  CAS  PubMed  Google Scholar 

  11. Fu Z, et al. Effects of raf kinase inhibitor protein expression on suppression of prostate cancer metastasis. J Natl Cancer Inst. 2003;95:878–89.

    CAS  PubMed  Google Scholar 

  12. Schuierer MM, et al. Reduction in Raf kinase inhibitor protein expression is associated with increased Ras-extracellular signal-regulated kinase signaling in melanoma cell lines. Cancer Res. 2004;64:5186–92. doi:10.1158/0008-5472.CAN-03-3861.

    Article  CAS  PubMed  Google Scholar 

  13. Surveillance Epidemiology and End Results Program Website. 1973–2003 Public Use Data. Available from: http//seer.cancer.gov/publicdata. Accessed 17 Aug 2006.

  14. Wanebo HJ, et al. Cancer of the stomach: A patient care study by the American College of Surgeons. Ann Surg. 1993;218:583–92. doi:10.1097/00000658-199321850-00002.

    Article  CAS  PubMed  Google Scholar 

  15. MacDonald JS. Gastric cancer—New therapeutic options. N Engl J Med. 2006;355:76–7. doi:10.1056/NEJMe068121.

    Article  CAS  PubMed  Google Scholar 

  16. Bonenkamp JJ, et al. Extended lymphnode dissection for gastric cancer. Dutch Gastric Cancer Group. N Engl J Med. 1999;340:908–14. doi:10.1056/NEJM199903253401202.

    Article  CAS  PubMed  Google Scholar 

  17. Hagan S, et al. Reduction of Raf-1 kinase inhibitor protein expression correlates with breast cancer metastasis. Clin Cancer Res. 2005;11:7392–7. doi:10.1158/1078-0432.CCR-05-0283.

    Article  CAS  PubMed  Google Scholar 

  18. Chatterjee D, et al. Inverse association between Raf Kinase inhibitory protein and signal transducers and activators of transcription 3 expression in gastric adenocarcinoma patients implications for clinical outcome. Clin Cancer Res. 2008;14:2994–3001. doi:10.1158/1078-0432.CCR-07-4496.

    Article  CAS  PubMed  Google Scholar 

  19. Shevde LA, Welch DR. Metastasis suppressor pathways—an evolving paradigm. Cancer Lett. 2003;198:1–20. doi:10.1016/S0304-3835(03)00304-5.

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

This work was supported by Scientific Research Projects of Sichuan Provincial Health Department (No:080216).

Author information

Authors and Affiliations

Authors

Corresponding authors

Correspondence to Xiao-Bo Du or Dong Wang.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Wang, J., Yang, YH., Wang, AQ. et al. Immunohistochemical detection of the Raf kinase inhibitor protein in nonneoplastic gastric tissue and gastric cancer tissue. Med Oncol 27, 219–223 (2010). https://doi.org/10.1007/s12032-009-9194-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12032-009-9194-z

Keywords

Navigation